My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Curis Inc (CRIS)
NASDAQ:CRIS

Curis Stock Analysis & Ratings

Curis Stock Analysis Overview

Smart Score
4
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Curis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

CRIS

CRIS Stock Stats

Previous Close$4.77
Open$4.77
Bid0 x 0
Ask0 x 0
Today’s Range$4.46 - $4.835
52-Week Range$1.09 - $17.40
Volume2.38M
Average Volume1.42M
Market Cap$411.33M
Beta2.85
P/E Ratio-10.8
EPS-0.44
Earnings DateMar 10, 2022

Company Description

Curis Inc

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Sector
Healthcare
Industry
Biotechnology
CEO
James E. Dentzer
Employees
28
ISIN
US2312692005
Address
128 Spring Street, Lexington, MA, 02421, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

CRIS FAQ

What was Curis’s price range in the past 12 months?
Curis lowest stock price was $1.09 and its highest was $17.40 in the past 12 months.
    What is Curis’s market cap?
    Curis’s market cap is $411.33M.
      What is Curis’s price target?
      The average price target for Curis is $21.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $27.00 ,the lowest forecast is $15.00. The average price target represents 378.84% Increase from the current price of $4.49.
        What do analysts say about Curis?
        Curis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Curis’s upcoming earnings report date?
          Curis’s upcoming earnings report date is Mar 10, 2022 which is in 96 days.
            How were Curis’s earnings last quarter?
            Curis released its earnings results on Nov 09, 2021. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.13 by $0.01.
              Is Curis overvalued?
              According to Wall Street analysts Curis’s price is currently Undervalued.
                Does Curis pay dividends?
                Curis does not currently pay dividends.
                What is Curis’s EPS estimate?
                Curis’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Curis have?
                Curis has 91,610,000 shares outstanding.
                  What happened to Curis’s price movement after its last earnings report?
                  Curis reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.13. Following the earnings report the stock price went down -0.666%.
                    Which hedge fund is a major shareholder of Curis?
                    Among the largest hedge funds holding Curis’s share is Maverick Capital ltd. It holds Curis’s shares valued at 59M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis